Business conduct
Novartis is committed to sustainable performance built on a solid foundation of ethical values at all levels of our business.
We have received recognition from key indices and rankings because we work to make this commitment a reality. In 2009, Novartis was:
- Named one of the leaders in the pharmaceutical sector in the Dow Jones Sustainability Index
- Ranked among the most respected companies in the world by Barron's magazine
Learn more on our corporate citizenship website
Lobbying
Novartis takes an active role in public-policy debates affecting our business. It is our responsibility to share our perspective, scientific knowledge and technical expertise with policymakers and regulatory authorities. It is also in our interest, as a good corporate citizen, to campaign for policies and regulations that favor ethical business conduct.
Trade associations aid in both of these goals while also raising standards across our industry and helping toward best-practice exchange.
We strive for constructive partnerships with governments and other stakeholders to increase access to medicine and health information while preserving incentives for research and innovation through competitive pricing.
In our lobbying and advocacy activities – as in all other areas of our business – we are governed by the Novartis Code of Conduct and we strive for integrity, openness, transparency and consistency in our business activities.
Learn more about our commitment to responsible lobbying on our corporate citizenship website
Ethical marketing
Novartis provides accurate information to healthcare professionals and consumers.
Citizenship in action
The Regional Psychosocial Support Initiative brings hope to AIDS orphans in Africa.
Corporate governance
We are fully committed to good corporate governance.
